Market Research Logo

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

This report studies the Viral Vectors and Plasmid DNA Manufacturing market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Viral Vectors and Plasmid DNA Manufacturing market by product type and applications/end industries.

In the last several years, global market of Viral Vectors and Plasmid DNA Manufacturing developed rapidly, with an average growth rate of 28.05%. In 2016, global revenue of Viral Vectors and Plasmid DNA Manufacturing is nearly 250 M USD.

The major players in global Viral Vectors and Plasmid DNA Manufacturing market include
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Brammer Bio
VGXI
PlasmidFactory

Geographically, this report is segmented into several key Regions, with revenue, Market Share and Growth Rate of Viral Vectors and Plasmid DNA Manufacturing in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
Asia-Pacific
South America
Middle East and Africa

On the basis of product, the Viral Vectors and Plasmid DNA Manufacturing market is primarily split into
Plasmid DNA
Viral Vectors


1 Viral Vectors and Plasmid DNA Manufacturing Market Overview
1.1 Viral Vectors and Plasmid DNA Manufacturing Product Overview
1.2 Viral Vectors and Plasmid DNA Manufacturing Segment by Types (Product Category)
1.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Comparison by Types (2012-2022)
1.2.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Types in 2016
1.2.3 Viral Vectors
1.2.4 Plasmid DNA
1.3 Global Viral Vectors and Plasmid DNA Manufacturing Segment by Applications
1.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Comparison by Applications (2012-2022)
1.3.2 Cancers
1.3.3 Inherited Disorders
1.3.4 Viral Infections
1.4 Global Viral Vectors and Plasmid DNA Manufacturing Market by Regions (2012-2022)
1.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size and Growth Comparison by Regions (2012-2022)
1.4.2 North America Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)
1.4.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)
1.4.4 Europe Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)
1.4.5 South America Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)
1.4.6 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)
1.5 Global Viral Vectors and Plasmid DNA Manufacturing Market Size (2012-2022)
2 Global Viral Vectors and Plasmid DNA Manufacturing Market Competition by Manufacturers/Brand
2.1 Global Viral Vectors Manufacturing Revenue and Share by Manufacturers (2016-2017)
2.2 Global Plasmid DNA Manufacturing Revenue and Share by Manufacturers (2016-2017)
2.3 Global Viral Vectors and Plasmid DNA Manufacturing Gross Margin by Manufacturers (2016-2017)
2.4 Manufacturers Viral Vectors and Plasmid DNA Manufacturing Headquarters, Established Date, Product Types
2.5 Viral Vectors and Plasmid DNA Manufacturing Market Competitive Situation and Trends
2.5.1 Viral Vectors and Plasmid DNA Manufacturing Market Concentration Rate
2.5.2 Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Viral Vectors and Plasmid DNA Manufacturing, Revenue by Regions (2012-2017)
3.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Regions (2012-2017)
3.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)
3.3 North America Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)
3.4 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)
3.5 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)
3.6 South America Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)
3.7 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)
4 Global Viral Vectors and Plasmid DNA Manufacturing Revenue, Growth Trend by Types
4.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Types (2012-2017)
4.2 Global Viral Vectors and Plasmid DNA Manufacturing Growth by Type (2012-2017)
5 Global Viral Vectors and Plasmid DNA Manufacturing Market Analysis by Applications
5.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Applications (2012-2017)
5.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Growth Rate by Applications (2012-2017)
6 Analysis of Viral Vectors and Plasmid DNA Manufacturing Industry Key Manufacturers
6.1 BioReliance
6.1.1 Company Profile
6.1.2 Product Information
6.1.3 Revenue, Cost, Gross Profit and Gross Margin
6.2 Cobra Biologics
6.2.1 Company Profile
6.2.2 Product Information
6.2.3 Revenue, Cost, Gross Profit and Gross Margin
6.3 Oxford BioMedica
6.3.1 Company Profile
6.3.2 Product Information
6.3.3 Revenue, Cost, Gross Profit and Gross Margin
6.4 UniQure
6.4.1 Company Profile
6.4.2 Product Information
6.4.3 Revenue, Cost, Gross Profit and Gross Margin
6.5 FinVector
6.5.1 Company Profile
6.5.2 Product Information
6.5.3 Revenue, Cost, Gross Profit and Gross Margin
6.6 MolMed
6.6.1 Company Profile
6.6.2 Product Information
6.6.3 Revenue, Cost, Gross Profit and Gross Margin
6.7 MassBiologics
6.7.1 Company Profile
6.7.2 Product Information
6.7.3 Revenue, Cost, Gross Profit and Gross Margin
6.8 Richter-Helm
6.8.1 Company Profile
6.8.2 Product Information
6.8.3 Revenue, Cost, Gross Profit and Gross Margin
6.9 FUJIFILM Diosynth Biotechnologies
6.9.1 Company Profile
6.9.2 Product Information
6.9.3 Revenue, Cost, Gross Profit and Gross Margin
6.10 Lonza
6.10.1 Company Profile
6.10.2 Product Information
6.10.3 Revenue, Cost, Gross Profit and Gross Margin
6.11 Aldevron
6.11.1 Company Profile
6.11.2 Product Information
6.11.3 Revenue, Cost, Gross Profit and Gross Margin
6.12 Eurogentec
6.12.1 Company Profile
6.12.2 Product Information
6.12.3 Revenue, Cost, Gross Profit and Gross Margin
6.13 Cell and Gene Therapy Catapult
6.13.1 Company Profile
6.13.2 Product Information
6.13.3 Revenue, Cost, Gross Profit and Gross Margin
6.14 Biovian
6.14.1 Company Profile
6.14.2 Product Information
6.14.3 Revenue, Cost, Gross Profit and Gross Margin
6.15 Brammer Bio
6.15.1 Company Profile
6.15.2 Product Information
6.15.3 Revenue, Cost, Gross Profit and Gross Margin
6.16 VGXI
6.16.1 Company Profile
6.16.2 Product Information
6.16.3 Revenue, Cost, Gross Profit and Gross Margin
6.17 PlasmidFactory
6.17.1 Company Profile
6.17.2 Product Information
6.17.3 Revenue, Cost, Gross Profit and Gross Margin
7 Viral Vectors and Plasmid DNA Manufacturing Manufacturing Cost Analysis
7.1 Viral Vectors and Plasmid DNA Manufacturing Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost Analysis
7.2.2.1 USA Labor Cost Analysis
7.2.2.2 Europe Labor Costs Analysis
7.2.2.3 Asia Labor Costs Analysis
7.2.3 Other Costs Analysis
7.2.3.1 USA Cost of Electricity Analysis
7.2.3.2 USA Water Cost Analysis
7.2.3.3 Europe Cost of Electricity Analysis
7.2.3.4 Europe Water Cost Analysis
7.2.3.5 China Cost of Electricity Analysis
7.2.3.6 China Water Cost Analysis
7.2.4 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
10 Market Effect Factors Analysis
10.1 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast (2017-2022)
11.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022)
11.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Regions (2017-2022)
11.2.1 North America Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022)
11.2.2 Europe Viral Vectors and Plasmid DNA Manufacturing and Revenue Forecast (2017-2022)
11.2.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022)
11.2.4 South America Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022)
11.2.5 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022)
11.3 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Type (2017-2022)
11.4 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Application (2017-2022)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Product Picture of Viral Vectors and Plasmid DNA Manufacturing
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Comparison by Types (Product Category) (2012-2022)
Figure Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Types in 2016
Figure Product Picture of Viral Vectors
Figure Product Picture of Plasmid DNA
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Comparison by Applications (2012-2022)
Figure Global Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Applications in 2016
Figure Cancers Examples
Figure Inherited Disorders Examples
Figure Viral Infections Examples
Figure Global Viral Vectors and Plasmid DNA Manufacturing Market Size (M USD) Comparison and Growth by Regions (2012-2022)
Table Global Market Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Comparison by Regions 2012-2022
Figure North America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)
Figure South America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)
Figure Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)
Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Status and Outlook (2012-2022)
Table Global Viral Vectors Revenue (M USD) of Key Manufacturers (2016-2017)
Table Global Viral Vectors Manufacturing Revenue Share by Manufacturers (2016-2017)
Figure 2016 Viral Vectors Manufacturing Revenue Share by Manufacturers
Figure 2017 Viral Vectors Manufacturing Revenue Share by Manufacturers
Table Global Plasmid DNA Manufacturing Revenue (M USD) by Manufacturers (2016-2017)
Table Global Plasmid DNA Manufacturing Revenue Share by Manufacturers (2016-2017)
Figure 2016 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Manufacturers
Figure 2016 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Manufacturers
Table Global Market Viral Vectors and Plasmid DNA Manufacturing Gross Margin of Key Manufacturers (2016-2017)
Figure Global Market Viral Vectors and Plasmid DNA Manufacturing Gross Margin of Key Manufacturers in 2016
Table Manufacturers Viral Vectors and Plasmid DNA Manufacturing Headquarters and Established Date
Table Manufacturers Viral Vectors and Plasmid DNA Manufacturing Product Category
Figure Viral Vectors and Plasmid DNA Manufacturing Market Concentration Rate
Figure Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 3 Manufacturers
Figure Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 5 Manufacturers
Table Mergers & Acquisitions, Expansion
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) by Regions (2012-2017)
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Regions (2012-2017)
Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Regions (2012-2017)
Figure 2016 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Regions
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017)
Table North America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017)
Table Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017)
Table South America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017)
Table Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017)
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) by Types (2012-2017)
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Types (2012-2017)
Figure Revenue Share of Viral Vectors and Plasmid DNA Manufacturing by Types (2012-2017)
Figure 2016 Revenue Market Share of Viral Vectors and Plasmid DNA Manufacturing by Types
Figure Global Viral Vectors and Plasmid DNA Manufacturing Growth by Type (2012-2017)
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) by Applications (2012-2017)
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Applications (2012-2017)
Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Applications (2012-2017)
Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Applications in 2016
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue Growth Rate by Applications (2012-2017)
Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Growth Rate by Applications (2012-2017)
Table BioReliance Company Profile
Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of BioReliance 2016-2017
Table Cobra Biologics Company Profile
Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Cobra Biologics
Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Cobra Biologics 2016-2017
Table Oxford BioMedica Company Profile
Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Oxford BioMedica
Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Oxford BioMedica 2016-2017
Table UniQure Company Profile

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report